These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31489970)
1. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production. Werumeus Buning A; Geersing TH; Crul M Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970 [TBL] [Abstract][Full Text] [Related]
2. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet. Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245 [TBL] [Abstract][Full Text] [Related]
4. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system. Federici M; Raffaelli J; Paolucci D; Schierl R; Krämer I J Occup Environ Hyg; 2019 Jan; 16(1):6-15. PubMed ID: 30230976 [TBL] [Abstract][Full Text] [Related]
6. Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system. Krämer I; Federici M Eur J Hosp Pharm; 2020 Jul; 27(4):209-215. PubMed ID: 32587079 [TBL] [Abstract][Full Text] [Related]
7. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Harrison BR; Peters BG; Bing MR Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258 [TBL] [Abstract][Full Text] [Related]
8. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. Sessink PJ; Connor TH; Jorgenson JA; Tyler TG J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932 [TBL] [Abstract][Full Text] [Related]
9. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents. Clark BA; Sessink PJ J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973 [TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs. Bartel SB; Tyler TG; Power LA Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374 [TBL] [Abstract][Full Text] [Related]
11. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
12. Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process. Valero S; López-Briz E; Vila N; Solana A; Melero M; Poveda JL Regul Toxicol Pharmacol; 2018 Jun; 95():1-7. PubMed ID: 29510165 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs. Telleria N; García N; Grisaleña J; Algaba N; Bergareche E; Tamés MJ; Cajaraville G J Oncol Pharm Pract; 2021 Sep; 27(6):1343-1353. PubMed ID: 32854575 [TBL] [Abstract][Full Text] [Related]
14. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding. Soefje S; Rickabaugh K; Rajkumar R; Wall KP Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding. Soefje S; Rickabaugh K; Rajkumar R; Wall KP Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a decontamination procedure in a pharmacy buffer room contaminated by 5 antineoplastic agents. Arpino P; Yeomelakis J; Oommen A Am J Health Syst Pharm; 2020 Dec; 77(24):2081-2088. PubMed ID: 33150407 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Robotic Systems on Cytotoxic Drug Preparation: A Systematic Review and Meta-Analysis. Shin S; Koo J; Kim SW; Kim S; Hong SY; Lee E Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984432 [No Abstract] [Full Text] [Related]
19. Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus. Soteriades ES; Economidou SC; Tsivitanidou A; Polyviou P; Lorimer A; Katodritis N; Theophanous-Kitiri S PLoS One; 2020; 15(3):e0216098. PubMed ID: 32134912 [TBL] [Abstract][Full Text] [Related]
20. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs. Geersing TH; Franssen EJF; Pilesi F; Crul M Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]